Pages that link to "Q46375225"
Jump to navigation
Jump to search
The following pages link to Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells (Q46375225):
Displaying 47 items.
- Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies (Q26829652) (← links)
- Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy (Q28082536) (← links)
- Anticancer activity of MPT0E028, a novel potent histone deacetylase inhibitor, in human colorectal cancer HCT116 cells in vitro and in vivo (Q28482468) (← links)
- Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy. (Q30831849) (← links)
- The mTOR inhibitor everolimus in combination with azacitidine in patients with relapsed/refractory acute myeloid leukemia: a phase Ib/II study (Q33437313) (← links)
- Targeting MYC Dependence by Metabolic Inhibitors in Cancer (Q33608493) (← links)
- SYK regulates mTOR signaling in AML. (Q33641643) (← links)
- The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients. (Q34024558) (← links)
- Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Q34260622) (← links)
- Small molecule inhibitors in acute myeloid leukemia: from the bench to the clinic (Q34817365) (← links)
- mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms (Q35053837) (← links)
- Autophagy regulates myeloid cell differentiation by p62/SQSTM1-mediated degradation of PML-RARα oncoprotein (Q35079502) (← links)
- mTOR kinase inhibitors synergize with histone deacetylase inhibitors to kill B-cell acute lymphoblastic leukemia cells (Q35273390) (← links)
- Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo (Q35741591) (← links)
- Histone Deacetylase Inhibitors Inhibit the Proliferation of Gallbladder Carcinoma Cells by Suppressing AKT/mTOR Signaling (Q35749913) (← links)
- Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia (Q36544778) (← links)
- Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo (Q36548059) (← links)
- Trichostatin A Enhances the Apoptotic Potential of Palladium Nanoparticles in Human Cervical Cancer Cells (Q37210234) (← links)
- Acute myeloid leukemia: potential for new therapeutic approaches targeting mRNA translation pathways (Q37364509) (← links)
- Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies (Q37432231) (← links)
- Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells (Q37564804) (← links)
- Histone deacetylases and the immunological network: implications in cancer and inflammation (Q37621256) (← links)
- TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms (Q37672563) (← links)
- Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies (Q37779489) (← links)
- The role of HDACs inhibitors in childhood and adolescence acute leukemias (Q37841146) (← links)
- Entinostat for treatment of solid tumors and hematologic malignancies (Q37925846) (← links)
- mTOR kinase inhibitors as a treatment strategy in hematological malignancies (Q37993588) (← links)
- Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics. (Q38502939) (← links)
- LRRC25 plays a key role in all-trans retinoic acid-induced granulocytic differentiation as a novel potential leukocyte differentiation antigen (Q38768045) (← links)
- Selective phosphorylation during early macrophage differentiation (Q38840798) (← links)
- Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential. (Q39119297) (← links)
- CS055 (Chidamide/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells (Q39395916) (← links)
- Inhibition of mTOR signaling by oleanolic acid contributes to its anti‐tumor activity in osteosarcoma cells (Q39605943) (← links)
- Pharicin B stabilizes retinoic acid receptor-α and presents synergistic differentiation induction with ATRA in myeloid leukemic cells (Q39663357) (← links)
- p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells (Q39762903) (← links)
- PLSCR1/IP3R1/Ca2+ axis contributes to differentiation of primary AML cells induced by wogonoside (Q41082499) (← links)
- The DAC system and associations with acute leukemias and myelodysplastic syndromes (Q41209862) (← links)
- Synergistic effects of phenylhexyl isothiocyanate and LY294002 on the PI3K/Akt signaling pathway in HL-60 cells (Q41614789) (← links)
- Potential of mTOR inhibitors as therapeutic agents in hematological malignancies (Q42807577) (← links)
- Translational research in complex etiopathogenesis and therapy of hematological malignancies: the specific role of tyrosine kinases signaling and inhibition (Q46218126) (← links)
- Combined inhibition of PI3K and mTOR exerts synergistic antiproliferative effect, but diminishes differentiative properties of rapamycin in acute myeloid leukemia cells. (Q53266494) (← links)
- Bufalin induces apoptosis in human esophageal carcinoma ECA109 cells by inhibiting the activation of the mTOR/p70S6K pathway. (Q54977984) (← links)
- Intersection of Epigenetic and Metabolic Regulation of Histone Modifications in Acute Myeloid Leukemia (Q92703951) (← links)
- Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells (Q92712275) (← links)
- Berberine Induces Autophagic Cell Death in Acute Lymphoblastic Leukemia by Inactivating AKT/mTORC1 Signaling (Q96132522) (← links)
- NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia (Q96685758) (← links)
- Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence (Q99549077) (← links)